157 related articles for article (PubMed ID: 3485429)
1. Hydroxycholecalciferols modulate parathyroid hormone and calcitonin sensitive adenylyl cyclase in bone and kidney of rats. A possible physiological role for 24,25-dihydroxy vitamin D3.
Gordeladze JO; Gautvik KM
Biochem Pharmacol; 1986 Mar; 35(6):899-902. PubMed ID: 3485429
[TBL] [Abstract][Full Text] [Related]
2. 1,25-dihydroxyvitamin D-3 and 24,25-dihydroxyvitamin D-3 affect parathormone (PTH) -sensitive adenylate cyclase activity and alkaline phosphatase secretion of osteoblastic cells through different mechanisms of action.
Klem KH; Jablonski G; Saether O; Jarosz G; Gautvik KM; Gordeladze JO
Biochim Biophys Acta; 1990 Sep; 1054(3):304-10. PubMed ID: 2169895
[TBL] [Abstract][Full Text] [Related]
3. Effects in vivo of vitamin D metabolites and 17 beta-estradiol on parathyroid hormone-dependent formation of adenosine 3',5'-monophosphate in rat bone.
Marcus R; Orner FB; Brickman AS
Endocrinology; 1980 Nov; 107(5):1593-9. PubMed ID: 6253269
[TBL] [Abstract][Full Text] [Related]
4. Renal effect of vitamin D metabolites: evidence for the essential role of the 25(OH) group.
Friedlaender MM; Kornberg Z; Wald H; Popovtzer MM
Am J Physiol; 1983 Jun; 244(6):F674-8. PubMed ID: 6602555
[TBL] [Abstract][Full Text] [Related]
5. Renal parathyroid hormone-dependent adenylate cyclase in vitamin D-deficient rats. Inhibition by hydroxylated vitamin D3 metabolites.
Cloix JF; d'Herbigny E; Ulmann A
J Biol Chem; 1980 Dec; 255(23):11280-3. PubMed ID: 6254964
[TBL] [Abstract][Full Text] [Related]
6. Long-term administration of vitamin D3 metabolites alters PTH-responsive osteoblastic adenylate cyclase in rats.
Mortensen B; Gordeladze JO; Aksnes L; Gautvik KM
Calcif Tissue Int; 1990 May; 46(5):339-45. PubMed ID: 2159835
[TBL] [Abstract][Full Text] [Related]
7. Effect of PTH and 1,25(OH)2D3 on renal 25(OH)D3 metabolism, adenylate cyclase, and protein kinase.
Armbrecht HJ; Wongsurawat N; Zenser TV; Davis BB
Am J Physiol; 1984 Jan; 246(1 Pt 1):E102-7. PubMed ID: 6320659
[TBL] [Abstract][Full Text] [Related]
8. The effect of vitamin D on bone in vivo.
Tam CS; Heersche JN; Jones G; Murray TM; Rasmussen H
Endocrinology; 1986 Jun; 118(6):2217-24. PubMed ID: 3486118
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D3 analogs and salmon calcitonin partially reverse the development of renal osteodystrophy in rats.
Jablonski G; Mortensen BM; Klem KH; Mosekilde L; Danielsen CC; Gordeladze JO
Calcif Tissue Int; 1995 Nov; 57(5):385-91. PubMed ID: 8564802
[TBL] [Abstract][Full Text] [Related]
10. The effect of parathyroid hormone (PTH) and 24,25-dihydroxy-vitamin D3 on adenylyl cyclase of iliac crest biopsies: diagnostic and prognostic tool for evaluation and treatment of uremic patients.
Gordeladze JO; Mortensen B; Nordal K; Halse J; Dahl E; Aksnes L; Gautvik KM
Scand J Clin Lab Invest Suppl; 1987; 186():13-20. PubMed ID: 3496656
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of parathyroid hormone on the renal 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 production of young and adult rats.
Armbrecht HJ; Wongsurawat N; Zenser TV; Davis BB
Endocrinology; 1982 Oct; 111(4):1339-44. PubMed ID: 6981502
[TBL] [Abstract][Full Text] [Related]
12. 24,25-dihydroxy vitamin D3 treatment inhibits parathyroid-stimulated adenylate cyclase in iliac crest biopsies from uremic patients.
Mortensen BM; Aarseth HP; Ganss R; Haug E; Gautvik KM; Gordeladze JO
Bone; 1993; 14(2):125-31. PubMed ID: 8334029
[TBL] [Abstract][Full Text] [Related]
13. Modulation of parathyroid hormone-sensitive adenylate cyclase in ROS 17/2.8 cells by dexamethasone 1,25-dihydroxyvitamin D3 and protein kinase C.
Rao LG; Wylie JN
Bone Miner; 1993 Oct; 23(1):35-47. PubMed ID: 8274878
[TBL] [Abstract][Full Text] [Related]
14. Antagonistic effects of 25(OH)vitamin D3 and peptide hormones on the activation of adenylate cyclase/cyclic AMP system in renal tissue in vitro.
Wald H; Popovtzer MM
Adv Exp Med Biol; 1980; 128():625-33. PubMed ID: 6252764
[No Abstract] [Full Text] [Related]
15. Comparative effects of some hydroxylated vitamin D metabolites on parathyrin secretion by dispersed rat parathyroid cells in vitro.
Gruson M; Demignon J; Del Pino Montes J; Miravet L
Steroids; 1982 Sep; 40(3):275-85. PubMed ID: 6985176
[TBL] [Abstract][Full Text] [Related]
16. Interaction between 24R,25-dihydroxycholecalciferol and 1,25-dihydroxycholecalciferol on 45Ca release from bone in vitro.
Mahgoub A
Calcif Tissue Int; 1981; 33(6):663-6. PubMed ID: 6799176
[TBL] [Abstract][Full Text] [Related]
17. Positive and negative regulations of the renal 25-hydroxyvitamin D3 1alpha-hydroxylase gene by parathyroid hormone, calcitonin, and 1alpha,25(OH)2D3 in intact animals.
Murayama A; Takeyama K; Kitanaka S; Kodera Y; Kawaguchi Y; Hosoya T; Kato S
Endocrinology; 1999 May; 140(5):2224-31. PubMed ID: 10218975
[TBL] [Abstract][Full Text] [Related]
18. Influence of a tumor promoting phorbol ester on the metabolism of 25-hydroxyvitamin D3.
Henry HL
Biochem Biophys Res Commun; 1986 Sep; 139(2):495-500. PubMed ID: 3490258
[TBL] [Abstract][Full Text] [Related]
19. Bone turnover in rats treated with 1,25-dihydroxyvitamin D3, 25-hydroxyvitamin D3 or 24,25-dihydroxyvitamin D3.
Mortensen BM; Gautvik KM; Gordeladze JO
Biosci Rep; 1993 Feb; 13(1):27-39. PubMed ID: 8392394
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D metabolites do not alter parathyroid hormone secretion acutely.
Magliola L; Anast CS; Forte LR
Bone Miner; 1986 Dec; 1(6):495-505. PubMed ID: 3509783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
